The U.S. Government Accountability Office (GAO) has issued a report that examines the Food and Drug Administration’s (FDA’s) approach to regulating health claims used by food manufacturers to promote their products. Titled “Food Labeling: FDA Needs to Reassess Its Approach to Protecting Consumers from False or Misleading Claims,” the report recommends that FDA seek authority from Congress to access evidence from food companies that would allow the agency to establish whether they can support their claims scientifically and provide guidance to industry “on the type and strength of scientific evidence needed to prevent false or misleading information in a structure/function claim.” While the report does not call for such claims to be prohibited, the GAO notes that the European Union does not allow qualified health claims on food labels, in part because FDA research has shown that consumers are confused by them.